The Genetic Aftermath: How Cancer Treatment Drives Mutation and Selection in Healthy Tissues
A pivotal study published in *Nature Genetics* investigates the long-term evolutionary consequences of cancer therapy on normal human tissues. The research examines how mutagenic treatments like chemotherapy and radiation create new genetic variation—acting as a powerful selective pressure—within healthy cell populations. This process can drive clonal expansion of cells carrying specific mutations, fundamentally altering tissue architecture and potentially creating a landscape for secondary health issues. The findings provide a critical window into somatic evolution, revealing how therapeutic interventions can accelerate microevolutionary processes such as genetic drift and selection outside the original tumor context.
Study Significance: For evolutionary biologists, this work offers a direct, human-relevant model of mutation and selection in action, bridging the gap between population genetics theory and somatic cell evolution. It underscores that evolutionary forces like selective pressure and genetic drift are not confined to generational timescales but operate dynamically within an organism’s lifespan following environmental insult. This has profound implications for understanding post-treatment health risks and reframes long-term patient monitoring through an evolutionary lens, where tissue fitness landscapes are permanently altered.
Source →Stay curious. Stay informed — with Science Briefing.
Always double check the original article for accuracy.
